Prevalence of Metabolic syndrome and its influence on microvascular complications in the Indian population with type 2 diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 14)

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Raman, Rajiv ^a   Gupta, Aditi ^a   Pal, Swakshyar S ^a   Ganesan, Suganeswari ^a   Venkatesh, Kadri ^a   Kulothungan, Vaitheeswaran ^b   Sharma, Tarun ^a  

^a SANKARA NETHRALAYA   (India)

^b Department of Preventive Ophthalmology ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; VIBRATION SENSE;

EID: 78149313142     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-67     Document Type: Article

References (30)

1. Banting lecture 1988. Role of insulin resistance in human disease. GM Reaven, Diabetes 1988 37 1595 607 10.2337/diabetes.37.12.1595 3056758
2. Cardiovascular morbidity and mortality associated with the metabolic syndrome. B Isomaa P Almgren T Tuomi B Forsen K Lahti M Nissen MR Taskinen L Groop, Diabetes Care 2001 24 683 9 10.2337/diacare.24.4.683 11315831
3. Metabolic syndrome and microangiopathy. A Szalat I Raz, Isr Med Assoc J 2006 8 424 5 16833174
4. Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications. Y Shimajiri K Tsunoda M Furuta Y Kadoya S Yamada K Nanjo T Sanke, Diabetes Res Clin Pract 2008 79 310 7 10.1016/j.diabres.2007.08.026 17933413
5. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. B Isomaaa M Henricsson P Almgren T Tuomi MR Taskinen L Groop, Diabetologica 2001 44 1148 54 10.1007/s001250100615 (Pubitemid 32842461)
6. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. G Marchesini G Forlani F Cerrelli R Manini S Natale L Baraldi G Ermini G Savorani D Zocchi N Melchionda, Diabet Med 2004 21 383 7 10.1111/j.1464-5491.2004.01115.x 15049944
7. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger G Targher M Alberiche RC Bonadonna M Muggeo, Diabetes 1998 47 1643 9 10.2337/diabetes.47.10.1643 9753305
8. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. C Alexander PB Landsman SM Teutsch SM Haffner, Diabetes 2003 52 1210 14 10.2337/diabetes.52.5.1210 12716754
9. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. LA Costa LH Canani HRK Lisboa GS Tres JL Gross, Diabetic Medicine 2004 21 252 5 10.1111/j.1464-5491.2004.01124.x 15008835
10. Insulin resistance, the metabolic syndrome, and complication risk in type 2 diabetes: double diabetes in the Diabetes Control and Complications Trial. ES Kilpatrick AS Rigby SL Atkin, Diabetes care 2007 30 707 12 10.2337/dc06-1982 17327345
11. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Metascreen Writing Committee RC Bonadonna D Cucinotta D Fedele G Riccardi A Tiengo, Diabetes care 2006 29 2701 07 10.2337/dc06-0942 17130208
12. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. R Kawasaki JM Tielsch JJ Wang TY Wong P Mitchell Y Tano M Tominaga T Oizumi M Daimon T Kato S Kawata T Kayama H Yamashita, Br J Ophthalmol 2008 92 161 6 10.1136/bjo.2007.127449 17965107
13. Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. T Iwasaki Y Togashi K Ohshige M Yoneda K Fujita A Nakajima Y Terauchi, Diabetes Res Clin Pract 2008 79 427 32 10.1016/j.diabres.2007.10.035 18207278
14. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of world. Seven Countries Study Research Group. PC Van den Hoogen EJ Feskens NJ Nagelkerke A Menotti A Nissinen, N Engl J Med 2000 342 1 8 10.1056/NEJM200001063420101 10620642
15. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. ET Lee H Keen PH Bennett JH Fuller M Lu, Diabetologia 2001 44 Suppl 2 3 13 10.1007/PL00002936 11587047
16. Japan diabetes complication study group. Obesity and type 2 diabetes in Japanese patients. H Sone H Ito Y Ohashi Y Akanuma N Yamada, Lancet 2003 361 85 10.1016/S0140-6736(03)12151-4 12517507
17. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. S Agarwal R Raman PG Paul PK Rani S Uthra R Gayathree C McCarty G Kumaramanickavel T Sharma, Ophthalmic Epidemiol 2005 12 143 53 10.1080/09286580590932734 16019696
18. Tests of glycemia in diabetes. DE Goldstein RR Little RA Lorenz JI Malone DM Nathan CM Peterson American Diabetes Association, Diabetes Care 2003 26 Suppl 1 106 108 12502632
19. Ethical principles and standards for the conduct of human and animal biological rhythm research. Y Touitou F Portaluppi MH Smolensky L Rensing, Chronobiol Int 2004 21 161 170 10.1081/CBI-120030045 15129830
20. New IDF worldwide definition of the metabolic syndrome. International Diabetes Federation, Press Conference 1st International Congress on 'Pre-diabetes' and the Metabolic Syndrome, Berlin, Germany 2005 http://www.idf.org/
21. An alternative method of grading diabetic retinopathy. R Klein BE Klein YL Magli RJ Brothers SM Meuer SE Moss MD Davis, Ophthalmology 1986 93 1183 7 3101021
22. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. CP Wilkinson FL Ferris RE Klein PP Lee CD Agardh M Davis D Dills A Kampik R Pararajasegaram JT Verdaguer Global Diabetic Retinopathy Project Group, Ophthalmology 2003 110 1677 82 10.1016/S0161-6420(03) 00475-5 13129861
23. Nephropathy in Diabetes. ME Molitch RA DeFronzo MJ Franz WF Keane CE Mogensen HH Parving MW Steffes American Diabetes Association, Diabetes Care 2004 27 Suppl 1 79 S83 14693934
24. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). R Pradeepa M Rema J Vignesh M Deepa R Deepa V Mohan, Diabet Med 2008 25 407 12 10.1111/j.1464-5491.2008.02397.x 18294224
25. Prevalence of Metabolic Syndrome in An Urban Indian Diabetic Population Using The NCEP ATP III Guidelines. SP Surana DB Shah K Gala S Susheja SS Hoskote N Gill SR Joshi V Panikar, J Assoc Physicians India 2008 56 865 8 19263684
26. Metabolic syndrome components in Indian migrants with type 2 diabetes. A matched comparative study. L Foucan J Deloumeaux JP Donnet J Bangou L Larifla C Messerchmitt LR Salmi P Kangambega, Diabetes Metab 2006 32 337 42 10.1016/S1262-3636(07)70288-4 16977261
27. Prevalence of metabolic syndrome in an Indian urban population. R Gupta PC Deedwania A Gupta S Rastogi RB Panwar K Kothari, Int J Cardiol 2004 97 257 61 10.1016/j.ijcard.2003.11.003 15458693
28. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. M Abdul-Ghani G Nawaf F Nawaf B Itzhak O Minuchin P Vardi, Isr Med Assoc J 2006 8 378 82 16833164
29. Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). R Raman PK Rani P Gnanamoorthy RR Sudhir G Kumaramanikavel T Sharma, Acta Diabetologica 2010 47 209 15 10.1007/s00592-009-0113-8 19326040
30. Renal manifestations of metabolic syndrome in type 2 diabetes. K Hanai T Babazono Y Iwamoto, Diabetes Res Clin Pract 2008 79 318 24 10.1016/j.diabres. 2007.08.032 17983681